(Q41119186)

English

Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs

scientific article published on August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs (English)

1 reference

Europe PubMed Central

27 September 2017

experimental infection

1 reference

based on heuristic

inferred from title

Dirofilaria repens

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

27 September 2017

2

0 references

author name string

Gabriele Petry

1

1 reference

Europe PubMed Central

27 September 2017

Marco Genchi

2

1 reference

Europe PubMed Central

27 September 2017

Holger Schmidt

3

1 reference

Europe PubMed Central

27 September 2017

Bettina Lawrenz

5

1 reference

Europe PubMed Central

27 September 2017

Claudio Genchi

6

1 reference

Europe PubMed Central

27 September 2017

publication date

1 August 2015

1 reference

Europe PubMed Central

27 September 2017

Parasitology Research

1 reference

Europe PubMed Central

27 September 2017

114 Suppl 1

1 reference

Europe PubMed Central

27 September 2017

S131-44

1 reference

Europe PubMed Central

27 September 2017

https://scigraph.springernature.com/pub.10.1007/s00436-015-4519-7

0 references

Dirofilaria repens infection in a dog: diagnosis and treatment with melarsomine and doramectin

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Macrocyclic lactones and Dirofilaria immitis microfilariae

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Stable transmission of Dirofilaria repens nematodes, northern Germany

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

5 S ribosomal spacer sequences of some filarial parasites: comparative analysis and diagnostic applications.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate, Bayer) spot-on

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Dirofilarial infections in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Treatment of Dirofilaria repens microfilariaemia with a combination of doxycycline hyclate and ivermectin

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Preliminary findings on the efficacy of selamectin in the treatment of dogs naturally infected with Dirofilaria repens

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Where are we with Wolbachia and doxycycline: an in-depth review of the current state of our knowledge

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Molecular detection of Dirofilaria immitis, Dirofilaria repens and Setaria tundra in mosquitoes from Germany

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Heartworm disease in animals and humans

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Current surveys on the prevalence and distribution of Dirofilaria spp. in dogs in Germany

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Discrimination between six species of canine microfilariae by a single polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Use of moxidectin tablets in the control of canine subcutaneous dirofilariosis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Use of an injectable, sustained-release formulation of moxidectin to prevent canine subcutaneous dirofilariosis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Human and animal dirofilariasis: the emergence of a zoonotic mosaic

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Canine and human Dirofilaria infections in the Balkan Peninsula

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Efficacy of a single administration of a spot-on solution containing imidacloprid 10%/moxidectin 2.5% in eliminating Dirofilaria repens microfilariae in naturally infected dogs

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

Efficacy of long-term monthly administration of ivermectin on the progress of naturally acquired heartworm infections in dogs

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4519-7

21 January 2018

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of anthelmintics for dogs and cats

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevention of Dirofilaria repens infection with ivermectin/pyrantel chewables.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of therapy by using advocate spot-on combination (imidacloprid 10% and moxidectin 2.5%) on subcutaneous dirofilariosis in dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental maintenance of Dirofilaria repens and D. immitis in dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy of ivermectin in preventing Dirofilaria repens infestation in dogs naturally exposed to contagion]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ivermectin against larval stages of Dirofilaria repens in dogs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First autochthonous case of canine ocular Dirofilaria repens infection in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of autochthonous human Dirofilaria infection, Germany, March 2014.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-015-4519-7

1 reference

Europe PubMed Central

27 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41119186&oldid=2094075781"